Skip to content
Stock screener

CNXU

Conviction 0HealthcareScan · Fri, Oct 9, 2026
Inverted hammer

Conexeu Sciences Inc. (CNXU) closed at $3.89 (+12.75%) on Oct 9, 2026. Its latest daily candle is a inverted hammer. Price is below its 50-day. RSI(14) 42, -77.0% from its 52-week high, -70.3% year to date. Sector: Healthcare · Biotechnology.

CNXU$3.89+12.75%
ResistanceSupportVol 14
63 bars
Vol MA14 208.14K
Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9
Conexeu Sciences Inc.Biotechnologywww.conexeu.com ↗
Price3.89
Change+12.75%
Gap+10.14%
Rel volume0.97×
Avg volume205.03K
Avg $ vol847.29K
SMA 204.04
SMA 506.01
SMA 200—
Price vs 50-35.45%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 4.41
RSI (14)42
MACD hist0.13
MACD cross—
Stoch %K / %D46 / 30
ADX (14)26
+DI / −DI23 / 28
RSI divergenceBullish
MACD divergenceBullish
ATR %13.27%
ADR %9.97%
52w high16.85
52w low3.10
From 52w high-76.97%
Above 52w low+25.16%
New 52w highNo
SqueezeOff
Bollinger width62.18%
%B0.44
Donchian pos34.29%
Donchian high5.47
Donchian low3.05
AVWAP (52w high)7.59
vs AVWAP high-48.85%
AVWAP (52w low)3.55
vs AVWAP low+9.39%
OBV trendDown
Chaikin MF (20)-0.21
Today vs 20d0.97×
Avg vol (14d)191.45K
Avg vol (20d)205.03K
Avg $ vol (20d)847.29K
Market cap109.44M
RS Rating—
RS 3m (vs SPY)-66.39%
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank23.4
1 week+25.16%
1 month-8.71%
3 months-62.48%
6 months—
1 year—
YTD-70.31%
P/E—
P/B18.71
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current5.31
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value107.47M
Revenue—
Net income-7.73M
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out25.27M
Employees—
ListedThu, May 21, 2026
Free float15.54M
Float %55.1%
Short interest202.49K
Days to cover0.6d
Short volume51.4%
Squeeze score13 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.29 vs −$0.10
Last surprise-190.0% miss
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank23.4 / 100
Group rank14 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmInverted hammer

Financials as of Fri, Jul 31, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in CNXU

All disclosures →
No recent disclosed trades by Congress in CNXU. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CNXU

InsiderSideShares
Sharpe Jeffrey Nathan
Director · Performance Warrants · 2026-09-14
Exercise500K
Sharpe Jeffrey Nathan
Director · Common Stock · 2026-09-14
Exercise500K
Purcell Lynn Sebastian
Director · Common Stock · 2026-09-04
Exercise217.61K
Purcell Lynn Sebastian
Director · Warrant · 2026-09-04
Exercise217.61K
Purcell Lynn Sebastian
Director · Common Stock · 2026-09-04
Exercise217.61K
Purcell Lynn Sebastian
Director · Warrant · 2026-09-04
Exercise217.61K
Wright Michael G.
10% owner · Common Stock · 2026-06-18
Exercise250K
Wright Michael G.
10% owner · Performance Warrants · 2026-06-18
Exercise250K
Wright Michael G.
10% owner · Common Stock · 2026-05-26
Exercise400K
Wright Michael G.
10% owner · Performance Warrants · 2026-05-26
Exercise400K

SEC filings

EDGAR filings in CNXU · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.